France vs Israel: Coverage of the human papillomavirus vaccine
France
51
in 2025
Israel
51
in 2025
France rank
62nd
Israel rank
62nd
Coverage of the human papillomavirus vaccine over time
- France
- Israel
How they compare
France currently reports 51 against 51 in Israel, a difference of 0.
Across all 10 years both countries report, Israel has been ahead every year.
France ranks 62nd and Israel ranks 62nd of 85 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.5 | 52.5 | 26 | Israel |
| 2020s | 44.67 | 54 | 9.33 | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher coverage of the human papillomavirus vaccine, France or Israel?
- France, at 51 against 51 in Israel as of 2025.
- What is the difference in coverage of the human papillomavirus vaccine between France and Israel?
- 0, with France ahead.
- How many years of comparable data are there for France and Israel?
- 10 years are reported by both, from 2016 to 2025.
- How do France and Israel rank globally for coverage of the human papillomavirus vaccine?
- France ranks 62nd and Israel ranks 62nd of 85 countries.
- Where does this data come from?
- Our World in Data, published as Coverage of the human papillomavirus vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.